Total Triterpenic Fraction of Centella asiatica in the Treatment of Venous Hypertension: A Clinical, Prospective, Randomized Trial Using a Combined Microcirculatory Model
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A single-blind, placebo-controlled, randomized study was performed on the effects of different doses of the total triterpenic fraction of Centella asiatica (TTFCA) in patients with venous hypertensive microangiopathy. A combined microcirculatory model that considers laser Doppler flowmetry (LDF) and transcutaneous oxygen (PO 2), transcutaneous carbon dioxide tension (PCO 2) measurements was combined with the symptom evaluation. LDF tests included the baseline resting flow, the venoarteriolar reflex, and the variation of flow related to the temperature increase. All tests provided a significant difference between drug-treated groups and the placebo group, thereby allowing a distinction to be made between the higher (120 mg daily) and the lower (60 mg daily) dose of TTFCA. Transcutaneous PO 2-PCO 2 measurements were significantly modified by drug treatments, while no variation could be detected in the placebo group. Important Symptomatologic effects (evaluated by subjective scores) followed TTFCA administration, especially at the higher dose level, while no effect was obtained with placebo. The trend of symptom evaluation paralleled the results of objective tests of our microcirculatory model, providing evidence that this model can reveal effects of venoactive drugs on venous hypertensive microangiopathy. TTFCA displays a significant activity. Doses as high as 120 mg daily may be safely used in venous hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE CAUSE OF VENOUS ULCERATION
Browse, N. L., & Burnand, K. G. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90325-7 · Cited by 572
Cited by
Centella asiatica: Phytochemistry and mechanisms of neuroprotection and cognitive enhancement
Gray, N. E., Alcazar Magana, A., Lak, P., Wright, K. M., Quinn, J., Stevens, J. F., Maier, C. S., & Soumyanath, A. (2018) · Phytochemistry Reviews · doi:10.1007/s11101-017-9528-y · Cited by 299
Sheng, H., & Sun, H. (2011) · Natural Product Reports · doi:10.1039/c0np00059k · Cited by 289
Biswas, D., Mandal, S., Chatterjee Saha, S., Tudu, C. K., Nandy, S., Batiha, G. E., Shekhawat, M. S., Pandey, D. K., & Dey, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7248 · Cited by 83
“In this study, daily doses as high as 120 mg was suggested as safe in patients with venous hypertension (Incandela et al., 2001).”
BackgroundSaeidinia, A., Keihanian, F., Lashkari, A. P., Lahiji, H. G., Mobayyen, M., Heidarzade, A., & Golchai, J. (2017) · Medicine · doi:10.1097/md.0000000000006168 · Cited by 70
“constitutes as seen in previous studies.[22-25] Burns are the most common forms of trauma.”
ResultKean, J., Downey, L., & Stough, C. (2017) · Medicines · doi:10.3390/medicines4040086 · Cited by 31
“asiatica on vascular injury in adults with improved microcirculatory parameters in chronic venous hypertensive patients [59,60], capillary permeability [50], and oedema’s in people suffering venous hypertension [61].”
Background
Metadata
- Authors
- Incandela, L., Belcaro, G., De Sanctis, M. T., Cesarone, M. R., Griffin, M., Ippolito, E., Bucci, M., & Cacchio, M.
- Venue
- Angiology
- Publisher
- SAGE Publications
- Published
- 2001-10
- Volume
- 52
- Issue
- 2_suppl
- Pages
- S61-S67
- ISSN
- 0003-3197 (ISSN-L)
- 1940-1574
- OpenAlex
- W63373986
- Cited by
- 33
- References
- 1
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Total Triterpenic Fraction of Centella asiatica in the Treatment of Venous Hypertension: A Clinical, Prospective, Randomized Trial Using a Combined Microcirculatory Model. https://app.cochat.ai/papers/10.1177/000331970105202s12
- The paper
- Incandela, L., Belcaro, G., De Sanctis, M. T., Cesarone, M. R., Griffin, M., Ippolito, E., Bucci, M., & Cacchio, M. (2001). Total Triterpenic Fraction of Centella asiatica in the Treatment of Venous Hypertension: A Clinical, Prospective, Randomized Trial Using a Combined Microcirculatory Model. Angiology. https://doi.org/10.1177/000331970105202s12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.